Though digital technology has improved the R&D process, when it comes to important clinical benefits and outcomes, modern biotech products have rarely shown the advantages of older generations of drugs.
Bagrat Lalayan
Advertisement
Bagrat Lalayan, M.D., Ph.D., is founder of Innovapharm and Victoria Consulting LLC (Armenia), and former GM of Armenian affiliates of Servier Laboratories (France), Roche (Switzerland).
Articles by Bagrat Lalayan
Advertisement
Latest Updated Articles
What's Behind the Clinical Innovation Gap?Published: March 31st 2018 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Applied Clinical Trials' 2025 State of the Industry Survey
2
Establishing Governance for No-Code AI in Clinical Operations
3
The Confidence Trap in Clinical Trials: When Knowing Just Enough Becomes Dangerous
4
Are Clinical Trial Diversity Initiatives at Risk of Being Dismantled?
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
